Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entero Therapeutics Inc
ENTO
Healthcare
Biotechnology
Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of...
celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for multiple GI conditions, including gastroparesis, and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. The Company also intends to develop Niclosamide, an oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, and immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 13, 2024 9:36am
ENTO.....looks like all the FWBI directors are resigning
Might be smoke & mirrors...might not New directors via Merger I guess
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Aug 13, 2024 9:35am
RE:ENTO.....20 cents
run*....not rn
Promino Nutritional Sciences Inc. Provides Shareholder Progress Report
posted Dec 14, 2024 9:00am by
Promino Nutritional Sciences Inc.
-
|
Promino Nutritional Science's rejuvenate muscle activator, delivers the equivalent of 40 grams of whey protein isolate for just 3.6 grams of the company’s product. That was just one of the highlights in the company’s update to investors covering a transformational period for the company as new management resurrects sales with an eye on the RTD market in 2025 ...read more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 13, 2024 9:20am
ENTO.....20 cents
I always said this was rn by a Dbag
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 09, 2024 10:55am
ENTO........On watch list ; )
low vol with some price action (small)
(282)
•••
whytestocks
X
Post by
whytestocks
on May 10, 2024 8:45pm
First Wave BioPharma, Inc. to raise approximately $1.1 milli
JUST IN: $FWBI First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-MarketBOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc
...more
(282)
•••
whytestocks
X
Post by
whytestocks
on Feb 27, 2024 3:00pm
(FWBI) Technical Pivots with Risk Controls
Breaking News: $FWBI (FWBI) Technical Pivots with Risk Controls2024-02-27 07:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 20, 2023 2:24pm
FWBI....LoL halted for nothing ????
weird
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 18, 2023 10:33am
FWBI.....RS effective this a.m and guess what
Heading south for the winter Mr. M ???? LoL.....u have never made any body money on your freaking deal....don't start now
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 14, 2023 9:20am
FWBI.....Guess what ? Yep....here comes another RS
First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders 2023-12-14 06:15 ET - News Release BOCA RATON, Fla., Dec. 14, 2023 (GLOBE
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 10, 2023 7:00am
New Press Release - Date and Time Announced for First Wave BioPharma CEO James Sapirstein's Presentation at the 2023 BIO Investor Forum
BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2023 7:00am
New Press Release - First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2023 11:25am
FWBI ....a past pick of mine
wasn't a good pick because the powers to be moved this sooooo low....eventually made some $'s on this I call this a "Devil Stock".....taking it off the watch list now.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 15, 2023 10:39am
FWBI.....sub 50 pesos again
No position....as of yesterday ; ) Cheers !
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 15, 2023 8:45am
New Press Release - First Wave BioPharma To Present at the BIO Investor Forum
BOCA RATON, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 14, 2023 3:27pm
FWBI .... Not sure how I missed this...but it didn't matter
Somehow I traded this like a Champ.... Cheers ! First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.